If you have an Aetna plan and you’re considering ketamine therapy for depression in New York, the answer depends entirely on which form of ketamine treatment you’re asking about.
Aetna recognizes two very different paths in 2026, and they’re treated very differently for coverage purposes. Spravato (FDA-approved esketamine nasal spray) has a defined coverage pathway when clinical criteria are met. IV ketamine infusion therapy is classified as experimental and is generally not covered.
This guide explains how Aetna actually handles ketamine-based treatment in 2026, what your realistic options look like, and where Ketamine Wellness New York fits in the picture. We’ll be honest about what we provide and what we don’t, so you can make an informed decision before you call any clinic.
By submitting this form you agree to be contacted via phone/text/email.
Ketamine Wellness New York provides IV ketamine infusion therapy only. We do not offer Spravato. We do not bill insurance, submit Prior Authorization requests, prepare superbills, or coordinate appeals.
If insurance coverage through Aetna is essential to your treatment plan, the relevant pathway is Spravato through a REMS-certified provider, not us. We mention this upfront because the rest of this guide explains both pathways honestly, and we’d rather you know where we fit before reading further.
Aetna’s coverage position comes down to one core distinction: whether the specific treatment carries FDA approval for the condition being treated.
Spravato (esketamine) received FDA approval in 2019 for treatment-resistant depression, and later for depression with acute suicidal ideation. Because it has FDA approval for a psychiatric indication, Aetna covers it as medically necessary when clinical criteria are met under Clinical Policy Bulletin #0950.
IV ketamine uses the original ketamine molecule, which has been FDA-approved as an anesthetic since 1970 but is not approved for depression, anxiety, PTSD, OCD, or chronic pain. Aetna’s Clinical Policy Bulletin #0938 classifies IV ketamine for these conditions as experimental, investigational, or unproven, and does not cover it under standard benefit structures.
This is the structural reason for almost every difference you’ll encounter when researching Aetna coverage. The treatment that has FDA approval for psychiatric use has a coverage pathway. The treatment that is used off-label generally does not.
If your clinician has recommended Spravato and you have an Aetna plan, here is what the coverage process generally looks like.
Aetna does not approve Spravato automatically. Several specific requirements must be documented before Prior Authorization is processed:
One of the most common reasons Aetna denies Spravato authorizations is incomplete treatment history. Aetna requires proof that you’ve tried at least two antidepressants from different pharmacological classes — for example, an SSRI and an SNRI, or a tricyclic.
Each medication must have been used at an adequate dose and for an appropriate duration (usually four weeks at therapeutic dose) without meaningful clinical improvement. Specific start dates, stop dates, doses, and reasons for discontinuation matter. Missing any of these details often triggers an automatic denial that has nothing to do with whether you actually have treatment-resistant depression.
Aetna has a separate Spravato pathway for major depressive disorder with acute suicidal ideation or behavior. This pathway recognizes that patients in crisis may not be able to wait through the standard treatment-resistant depression process.
For this pathway, the documentation must be more urgent and more specific. The clinical record should clearly show current suicidal ideation, the severity and immediacy of clinical risk, why standard outpatient adjustment isn’t sufficient, and the prescriber’s rationale for requesting Spravato.
This pathway should never be treated as a shortcut. It exists for urgent clinical situations where fast access may materially affect patient safety. If you or someone in your family is facing this level of urgency, do not wait for a website form. Call 988, call 911, or go to the nearest emergency department. Once safety is addressed, treatment planning can follow.
To pursue Spravato through Aetna, you’ll need to identify a REMS-certified provider in your network. Your existing psychiatrist or primary care physician can often coordinate the referral, and Aetna’s member services line can confirm in-network options.
Ketamine Wellness New York is not a Spravato provider. If you’re seeking the Spravato pathway, your time is better spent finding a REMS-certified clinic than contacting us.
This is where the conversation gets more direct.
Aetna’s Clinical Policy Bulletin #0938 classifies IV ketamine as experimental, investigational, or unproven for depression, PTSD, and chronic pain. This isn’t a comment on whether IV ketamine has clinical value — substantial research has explored ketamine’s effects on glutamate signaling and synaptic plasticity. The classification reflects Aetna’s standard policy of building coverage around FDA-approved indications.
Ketamine is FDA-approved as an anesthetic. Its use for depression and other psychiatric conditions is off-label. For insurance purposes, “off-label” generally means “not covered” under Aetna’s standard benefit structure. This is the same position taken by most major insurers, not just Aetna.
If you have an Aetna plan and want IV ketamine, the realistic options are:
Some clinics market the possibility of partial reimbursement through superbills submitted to out-of-network benefits. The reality is that reimbursement for off-label IV ketamine is uncertain in most plans, and even when partial reimbursement is possible, the amounts are typically modest.
Ketamine Wellness New York operates as a cash-pay IV ketamine clinic. We do not prepare formal superbills, do not advise on coding, and do not coordinate insurance reimbursement attempts. A standard receipt is available upon request, which you can submit to your insurer if you wish, but we make no claims about whether reimbursement will succeed.
If recovering insurance reimbursement is essential to your treatment plan, a clinic that specifically markets superbill preparation and insurance coordination is a better starting point than ours.
Your Aetna plan type — HMO, PPO, or POS — affects which paths are realistically accessible.
Aetna HMO members typically have Spravato coverage available when in-network providers and clinical criteria are met. Out-of-network options are limited or unavailable for most plans, which means out-of-network IV ketamine reimbursement is generally not on the table.
Aetna PPO members generally have the most flexibility. Spravato coverage is available with in-network providers, and PPO plans may offer some out-of-network benefits that could theoretically apply to IV ketamine services, though reimbursement remains uncertain.
Aetna POS members fall in between, often with referral requirements that affect timing more than coverage.
Aetna Medicare Advantage members should expect coverage to depend on the specific plan’s medical and pharmacy benefit rules. Manufacturer commercial savings programs like SPRAVATO withMe are generally not available to Medicare patients.
Before choosing any treatment path, verify your plan type and network rules with Aetna member services directly.
For commercially insured Aetna members receiving Spravato, the SPRAVATO withMe Savings Program may reduce medication costs significantly. According to the program’s published terms, eligible patients may pay as little as $10 per treatment for Spravato medicine costs, subject to annual limits and program rules.
This program does not cover all costs. Office visit, observation, and administration components may still be billable depending on your plan. Medicaid and Medicare patients are generally not eligible for commercial manufacturer savings programs.
If you’re pursuing Spravato through an in-network provider, ask about SPRAVATO withMe eligibility during your benefits verification. Your provider’s administrative team should be able to walk you through the application.
A denial isn’t always final. The most common reasons for denial include missing medication history, insufficient duration of prior antidepressant trials, incomplete rating scales, unclear diagnosis documentation, missing psychiatrist documentation, or plan-specific benefit exclusions.
Possible next steps include:
The clinic that submitted the original Spravato request is your best partner for these appeals. They have the records, the clinical relationship, and the experience with Aetna’s specific preferences.
Ketamine Wellness New York does not handle Spravato denials or appeals because we are not a Spravato provider.
For patients who choose IV ketamine outside of insurance coverage, here is what we provide at our Jackson Heights, Queens and Great Neck, Long Island locations.
Our care is led by Dr. Pervaiz Qureshi, a board-certified internal medicine physician with experience at NYU Medical Center, Brooklyn Hospital, and Henry J. Carter Hospital. We focus on addressing the underlying drivers of mental health conditions and chronic pain rather than managing symptoms in isolation.
Our pricing is transparent and includes full physician oversight:
That is the entire fee structure. There are no facility charges, no observation fees, no monitoring add-ons, and no maintenance enrollment costs. When you complete a session, the transaction is finished.
For most patients, the standard initial course is a six-session induction protocol over two to three weeks. After that, your physician assesses your response and discusses whether maintenance is clinically warranted.
If you’re an Aetna member trying to decide between paths, the practical comparison looks like this.
The Spravato path through Aetna offers established insurance coverage, manufacturer savings that can dramatically reduce drug costs for eligible commercial plans, structured documentation requirements, and a more predictable financial picture for patients who meet treatment-resistant depression criteria. It’s limited to depression diagnoses (not approved for anxiety, PTSD, OCD, or chronic pain), requires REMS-certified providers, and involves Prior Authorization processes that can delay treatment.
The cash-pay IV ketamine path offers faster access (typically within days of consultation), broader applicability across depression, anxiety, PTSD, OCD, and chronic pain, clinical protocol flexibility, and price transparency. It requires paying out of pocket, comes with no insurance safety net, and represents a meaningful financial commitment ($3,150 for a six-session induction at our clinic).
Neither path is universally right. The right choice depends on your specific diagnosis, your plan type, your urgency, and your financial situation.
Generally, no. Aetna’s Clinical Policy Bulletin #0938 classifies IV ketamine for depression, PTSD, and chronic pain as experimental, investigational, or unproven, and does not cover it under standard benefit structures. Coverage may be considered on a case-by-case basis for specific medical situations, but routine coverage is not standard.
Yes, when clinical criteria are met. Aetna covers Spravato as medically necessary for adults with treatment-resistant depression who have documented failure of at least two antidepressants from different drug classes. Treatment must occur in a REMS-certified clinical setting.
No. We operate on a cash-pay basis and do not bill insurance, submit Prior Authorization, prepare superbills, or coordinate appeals.
No. We provide IV ketamine infusion therapy only. Patients seeking the Aetna-covered Spravato pathway should look for a REMS-certified provider in their network.
Many patients use HSA or FSA funds for physician-prescribed medical treatment, but eligibility depends on your specific plan rules. Confirm with your account administrator before treatment, and ask whether a letter of medical necessity is required.
Reimbursement for off-label IV ketamine is uncertain in most plans. We can provide a standard receipt for your session, which you may submit to Aetna if you choose, but we do not prepare formal superbills, do not advise on billing codes, and do not follow up on reimbursement submissions. We make no claims about whether reimbursement will succeed.
Spravato pricing without insurance varies but is generally significantly higher than IV ketamine on a per-session basis. The SPRAVATO withMe Savings Program may reduce drug costs substantially for eligible commercially insured patients.
SPRAVATO withMe is a manufacturer-sponsored savings program that works with eligible commercial insurance plans, including Aetna, to lower Spravato medicine costs. Eligible patients may pay as little as $10 per treatment for the drug portion, subject to program rules and limits. Medicaid and Medicare patients are generally not eligible.
Most Aetna Prior Authorizations for Spravato are resolved within 3 to 5 business days when documentation is complete. Delays usually occur when the insurer requires additional documentation regarding previous antidepressant treatments.
The question “does Aetna cover ketamine therapy” has a clear answer once you separate the two treatments. Spravato has a defined coverage pathway when clinical criteria are met. IV ketamine generally does not.
If you have an Aetna plan and Spravato fits your clinical situation, that’s the pathway worth pursuing through a REMS-certified provider. If you’re seeking IV ketamine for any reason — broader diagnostic range, faster access, clinical protocol flexibility, or because Spravato isn’t appropriate for your diagnosis — you’ll be paying out of pocket at most clinics, including ours.
Ketamine Wellness New York is a cash-pay IV ketamine practice in Queens and Long Island, led by Dr. Pervaiz Qureshi. We don’t handle insurance, and we don’t pretend to. If our model fits your situation, we welcome the conversation. If you need insurance-covered treatment through Aetna, we hope this guide helps you find the right path elsewhere.
To schedule an initial consultation at our Jackson Heights, Queens or Great Neck, Long Island location, contact us directly. We’ll walk through your situation, give you a clear sense of cost, and tell you honestly whether IV ketamine is worth pursuing for your specific case.
The room is dark. The blinds are shut. Even soft light sends pain radiating behind
The burning never fully stops. It’s there when you wake up, when you try to
The cost of a single IV ketamine infusion in 2026 typically falls between $400 and
You did the work. You spoke with your psychiatrist, gathered your medication history, submitted the
If you have an Aetna plan and you’re considering ketamine therapy for depression in New
Ketamine therapy, particularly in the form of intravenous (IV) infusions, has become a go-to treatment
Living in New York City often means paying a premium for everything, from rent to
For many individuals living with obsessive-compulsive disorder (OCD), the mind feels like a transmission with
Ketamine therapy is gaining popularity for its ability to alleviate severe depressive symptoms in hours
Finding affordable mental healthcare in New York can feel like navigating a maze, especially when
For many, therapy offers a vital path to healing and self-discovery. However, after years of
New York City’s relentless pulse can at times push its residents to the brink. The
Navigating the bustling rhythm of New York City can make even routine tasks feel like
Embarking on a journey with ketamine therapy can be a significant step toward mental wellness,
Treatment-resistant depression (TRD) can leave many exhausted and without hope after conventional treatments fail. When
Experiencing severe anxiety or post-traumatic stress disorder (PTSD) can feel like an unending struggle, especially
Considering ketamine therapy in New York City can feel overwhelming, with a growing number of
Living with chronic pain can be an isolating and debilitating experience, often leading to a
The growing hope for ketamine therapy in treating conditions like depression and chronic pain is
Imagine a snow-covered hill where sledders have repeatedly carved deep, unchanging ruts, making it nearly
Thank you for choosing Wellness Clinic. Our specialist care team will contact you within the next 12 hours to confirm your appointment and answer any questions youmay have.
our team will review your message and contact your shortly. we look forward to supporting your wellness journey
Check your phone or email to receive your unique coupon code. You’ll need it when booking your first appointment.
